Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

January 26, 2015

Spectranetics Launches Stellarex DCB in Europe

January 27, 2015—Spectranetics Corporation announced the European launch of its Stellarex drug-coated balloon in Europe. The launch follows the completion of Spectranetics’ acquisition of the device from Covidien upon closure of Covidien’s acquisition by Medtronic, Inc.

According to Spectranetics, the paclitaxel-coated Stellarex device with EnduraCoat technology is used to restore and maintain blood flow to the arteries of the leg in patients with peripheral arterial disease. The device received European CE Mark approval in December 2014. The company expects to launch the device in the United States in 2017 after receiving US Food and Drug Administration approval. 

Advertisement

January 27, 2015

Early Results Presented at STS for Gore's Thoracic Single Side Branch Endograft

left-arrow Created with Sketch. Previous Article

January 27, 2015

Early Results Presented at STS for Gore's Thoracic Single Side Branch Endograft

Next Article right-arrow Created with Sketch.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button
)